PCUMex survey: Controversies in the management of prostate cancer among Mexican urologists

Q4 Medicine Revista mexicana de urologia Pub Date : 2016-05-01 DOI:10.1016/j.uromx.2015.12.007

C.I. Villeda-Sandoval, J.A. Rivera-Ramírez, G. Romero-Veléz, A. Lisker-Cervantes, R.A. Castillejos-Molina, M.S. de Zavaleta

{"title":"PCUMex survey: Controversies in the management of prostate cancer among Mexican urologists","authors":"C.I. Villeda-Sandoval, J.A. Rivera-Ramírez, G. Romero-Veléz, A. Lisker-Cervantes, R.A. Castillejos-Molina, M.S. de Zavaleta","doi":"10.1016/j.uromx.2015.12.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Prostate cancer is the first cause of mortality related to malignancy in Mexican men. Common clinical practice has to be evaluated in order to gain a picture of reality apart from the guidelines.</p></div><div><h3>Aim</h3><p>To analyze clinical practice among urologists in Mexico in relation to prostate cancer management and to compare the results with current recommendations and guidelines.</p></div><div><h3>Methods</h3><p>We collected the data from 600 urologists, members of the <em>Sociedad Mexicana de Urología</em>, who were invited by email to answer a survey on their usual decisions when managing controversial aspects of prostate cancer patients.</p></div><div><h3>Results</h3><p>Quinolones were the most common antibiotic used as prophylaxis in prostate biopsy (75.51%); 10–12 cores were taken in more than 65% of prostate biopsies; and 18.27% of the participants performed limited pelvic lymphadenectomy. Treatment results showed that 10.75% of the urologists surveyed preferred radical prostatectomy as monotherapy in high-risk patients with extraprostatic extension and 60.47% used complete androgen deprivation in metastatic prostate cancer.</p></div><div><h3>Conclusions</h3><p>There are many areas of opportunity for improvement in our current clinical practice for the management of patients with prostate cancer.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.12.007","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista mexicana de urologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2007408516000185","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

Background

Prostate cancer is the first cause of mortality related to malignancy in Mexican men. Common clinical practice has to be evaluated in order to gain a picture of reality apart from the guidelines.

Aim

To analyze clinical practice among urologists in Mexico in relation to prostate cancer management and to compare the results with current recommendations and guidelines.

Methods

We collected the data from 600 urologists, members of the Sociedad Mexicana de Urología, who were invited by email to answer a survey on their usual decisions when managing controversial aspects of prostate cancer patients.

Results

Quinolones were the most common antibiotic used as prophylaxis in prostate biopsy (75.51%); 10–12 cores were taken in more than 65% of prostate biopsies; and 18.27% of the participants performed limited pelvic lymphadenectomy. Treatment results showed that 10.75% of the urologists surveyed preferred radical prostatectomy as monotherapy in high-risk patients with extraprostatic extension and 60.47% used complete androgen deprivation in metastatic prostate cancer.

Conclusions

There are many areas of opportunity for improvement in our current clinical practice for the management of patients with prostate cancer.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

PCUMex调查:墨西哥泌尿科医生在前列腺癌治疗中的争议

背景:前列腺癌是墨西哥男性恶性肿瘤死亡的第一大原因。必须对常见的临床实践进行评估，以便获得除指南之外的现实情况。目的分析墨西哥泌尿科医生在前列腺癌管理方面的临床实践，并将结果与目前的建议和指南进行比较。方法我们收集了600名泌尿科医生的数据，他们是墨西哥社会Urología的成员，我们通过电子邮件邀请他们回答一项关于他们在处理前列腺癌患者有争议方面的通常决定的调查。结果喹诺酮类药物是前列腺活检中预防使用最多的抗生素(75.51%);超过65%的前列腺活检取了10-12芯;18.27%的参与者行有限盆腔淋巴结切除术。治疗结果显示，10.75%的受访泌尿科医师首选根治性前列腺切除术作为前列腺外伸高危患者的单一治疗方法，60.47%的受访泌尿科医师选择完全雄激素剥夺治疗转移性前列腺癌。结论目前前列腺癌患者的临床治疗还有很多需要改进的地方。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Revista mexicana de urologia Medicine-Urology

CiteScore

0.20

自引率

0.00%

发文量

期刊介绍： Revista Mexicana de Urología (RMU) [Mexican Journal of Urology] (ISSN: 0185-4542 / ISSN electronic: 2007-4085) is bimonthly publication that disseminates research by academicians and professionals of the international medical community interested in urological subjects, in the format of original articles, clinical cases, review articles brief communications and letters to the editor. Owing to its nature, it is publication with international scope that disseminates contributions in Spanish and English that are rigorously reviewed by peers under the double blind modality. Neither journalistic documents nor those that lack rigorous medical or scientific support are suitable for publication.